{'fraction_non_alphanumeric': 0.03545606229143493, 'fraction_numerical': 0.024193548387096774, 'mean_word_length': 5.077313054499366, 'pattern_counts': {'":': 0, '<': 3, '<?xml version=': 0, '>': 5, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 1, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week

Cite this article as: Yıldırım Köpük Ş, Çakıroğlu Y, Ceylan Y, Çekmen MB, Yücesoy G. Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. Eur Arch Med Res 2019;35(3):137-42 Received: 10.12.2017 Accepted: 03.09.2018 Address for Correspondence: Şule Yıldırım Köpük, Ümraniye Training and Research Hospital, Clinic of Obstetrics and Gynecology, İstanbul, Turkey Phone: +90 505 474 11 32 E-mail: suleyildirim@msn.com ORCID ID: orcid.org/0000-0002-5020-8323 Objective: We aimed to evaluate the prediction of preeclampsia by maternal serum pregnancy-associated plasma protein A (PAPP-A), placental growth factor (PIGF), sEndoglin (sEng) and uterine artery Doppler examination. Methods: One hundred and ninety-three singleton pregnant women admitted to outpatient clinic at 11-13+6 weeks for first trimester combined screening test were included in the study. Maternal history was taken, and uterine artery Doppler examination and serum biomarker screening (PAPP-A, PIGF, sEndoglin) were conducted. The follow-up results of pregnancy were recorded. The study cohort was divided into two groups as “control” and “preeclampsia”. Mann-Whitney U and chi-square tests were used for comparison of independent variables. Sensitivity and specificity for the predictive values of the significant parameters were calculated from ROC curves. Results: Of 193 women, 168 women (87%) were in the control group (group 1) and 25 women (12.9%) who developed preeclampsia were defined in the preeclampsia group. In preeclampsia group, 20 women (10.3%) with gestational hypertension and mild preeclampsia were defined as “group 2”, and five women (2.5%) with severe preeclampsia and hemolysis, elevated liver enzymes, low platelet were defined as “group 3”. Maternal serum PAPP-A, PIGF, sEng levels were not significantly different between preeclampsia group and control group, whereas uterine artery Doppler pulsatility index (PI) values were significantly higher in preeclampsia group (p=0.023). sEng levels were significantly higher in group 3 than those in group 2 (p=0.001). If uterine artery PI cut-off level was taken as >2.23 in ROC curve analysis, sensitivity was 42.31% and specificity was 82.10% for detecting preeclampsia. Conclusion: Maternal serum PAPP-A, PIGF and sEng were not effective in predicting preeclampsia. However, these markers can be used to distinguish between mild and severe preeclampsia. First trimester uterine artery Doppler examination is an effective screening method for predicting preeclampsia.


INTRODUCTION
Preeclampsia (PE) affects approximately 2% of all pregnancies and it is the most significant cause of maternal perinatal mortality and morbidity (1). Today, early detection of PE has become one of the fundamental goals of perinatal medicine. Although clinical symptoms of PE emerge after 20 th week of gestation, trophoblast invasion that is responsible for pathogenesis occurs in the first trimester (2). High-resistant spiral arteries can be detected from the 11 th week of gestation by uterine artery (UtA) Doppler examination (3). Therefore, first trimester UtA Doppler examination may be a good noninvasive method for predicting PE that reflects abnormal trophoblast invasion. The addition of maternal history and biochemical serum markers to UtA Doppler examination is strongly associated with placental and endothelial dysfunction (4). These markers make screening relatively earlier, and most importantly, when used with first trimester Doppler sonography, they provide higher predictive value and more advanced diagnostic performance (5). Placental growth factor (PIGF) and vascular endothelial growth factor (VEGF) are potent angiogenic factors and they have a stimulating effect on endothelial cell proliferation and migration. Soluble fms-1ike tyrosine kinase 1 (sFlt-1) and soluble endoglin (sEng) are anti-angiogenic factors and it is suggested that hypoxic placenta secretes increased amounts of sFlt-1 and sEng (6,7). Although there are contradictory results in the studies, it has been generally reported that the levels of angiogenic factors, PIGF and VEGF, are decreased in PE and the levels of anti-angiogenic factors, sFlt-1 and sEng, are increased (8). In addition, pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (f-ßhCG) have been used for chromosomal abnormality screening tests, and they have been also investigated in the prediction of complications that emerge in advanced gestational weeks in many studies and their availability has been discussed (9). Studies have shown that especially low PAPP-A levels may be closely associated with PE (10). Prediction of PE prediction has an important role in the prevention of complications associated with PE. Based on this reality, we intended to investigate the possible relationship between the development of PE development and maternal serum PIGF, sEng, PAPP-A, f-βhCG levels that were measured at 11+0 and 13+6 weeks of gestation and UtA pulsatility index (PI) values determined by Doppler ultrasonography.

METHODS
Singleton pregnant women who admitted for screening test at 11+0 and 13+6 weeks of gestation were included in the study. The study was planned as a prospective cohort study. Ethics committee approval was taken and cases were informed about the study. Exclusion criteria were determined as pregnancy greater than 14 weeks, multiple pregnancy, chromosomal or congenital fetal abnormality, chronic hypertension, molar pregnancy, type 1 diabetes mellitus, maternal renal disease, PE history and morbid obesity. Detailed maternal history was taken, ad nuchal translucency measurement and UtA Doppler examination were done. When consecutive similar wave patterns were obtained, PI was measured; mean PI values of right and left UtAs were calculated. Doppler measurement of the UtA PI at 11-13+6 weeks was performed by the same experienced sonographer. PAPP-A and f-βhCG were studied from blood samples. Measurements were performed using Immulite 2000 systems autoanalyzer with Siemens kits and by chemiluminescence method. The measurements were converted to multiple of median (MoM) values. Centrifuged blood samples were stored at -80 ˚C to analyze PIGF and sEng levels. After the completion of the study groups, human sEng/CD105 ELISA (Aviscera Biscience, Inc. Santa Clara, USA) and PIGF ELISA (DRG Instruments GmbH, Germany) kits were tested using micro-ELISA method by Radim Aliysei instrument in stored serum samples.
Characteristics, medical history, pregnancy outcomes, sonography findings, systolic and diastolic blood pressure values, pregnancy complications, PIGF, sEng, MoM values of PAPP-A and f-βhCG of the cases were recorded in computer database. PE diagnosis was made when two different blood pressure measurements, measured every 4 hours, were 140/90 mmHg and above, and presence of 300 mg or more protein in the urine within 24 hours or presence of 30 mg/dL (1+dipstick) protein in spot urine sample following 20 th weeks of pregnancy. According to ACOG criteria, PE group was divided into two groups as severe (group 3) and mild PE (group 2) (11). In case of only high blood pressure, gestational hypertension (GHT) was diagnosed; and in case of additional hemolysis, increase in liver enzymes and thrombocytopenia to PE-eclampsia table, hemolysis, elevated liver enzmymes, low platelet (HELLP) was diagnosed (12). Group 1 was composed of pregnant women who did not develop complications and group 2 was composed of patients with the diagnosis of PE, GHT and HELLP.

Statistical Analysis
SPSS (Statistical Package of Social Sciences) 16 evaluation version was used in the analysis of collected data. Mann-Whitney U test was used for statistical assessment and chi-square test was used for the comparison of classifier data. The differences between mild PE, severe PE and control group in terms of independent variables were analyzed by Kruskal Wallis test. The correlations between the variables were determined by Spearman correlation analysis. Results were evaluated at 95% confidence interval and significance was evaluated at p<0.05 level.

RESULTS
The study was performed on 250 pregnant women between 16-41 years of age who admitted to Kocaeli University Faculty of Medicine, Department of Obstetrics and Gynecology between February 2012 and 2014. Fifty-seven cases from whom we could not get pregnancy outcomes were excluded from the study. Out of patient group including 193 cases with serum PAPP-A, f-βhCG, PIGF and sEng measurements performed in 11-14 weeks of gestation and with known pregnancy outcomes, 168 women were not affected by PE, whereas PE was detected in 25 women including severe PE in 4 cases, mild PE in 18 cases, GHT in 2 cases and HELLP in one case. Patients with uncomplicated pregnancy were classified as group 1 (n=168), and patients diagnosed with mild PE, severe PE, GHT and HELLP were classified as group 2 (n=25). None of the pregnant women included in the study had a history of smoking or pregnancy with assisted reproductive techniques in vitro fertilization. Demographic characteristics and pregnancy outcomes of the patients are given in Table 1. When preeclamptic and normotensive patients were compared based on maternal age, gravida, parity, body mass index, delivery week and values, no statistically significant difference was found (p>0.05) ( Table 1). There was a significant difference in terms of birth weight of the newborn, mean arterial systolic pressure and mean diastolic pressure (p<0.05). There was no statistically significant difference between preeclamptic and control groups in terms of PIGF, sEng, PAPP-A, f-βhCG serum markers. UtA PI (p=0.023) and systolic diastolic (p=0.019) ratio were significantly higher in the preeclamptic group. The groups are shown in Table  1.When we classified cases as control group (n=168), patients who developed mild PE and GHT (n=20) (group 2), and patients who developed severe PE and HELLP (n=5) (group 3), sEng level in group 3 was significantly higher than in group 2 ( Table 2). PIGF level was relatively decreased in group 3 compared to group 2, however it was not statistically significant. PAPP-A MoM value was found to be significantly lower in group 3 compared to group 2. These results are summarized in Table 2. Prediction of PE could be made by ROC analysis with a PI cut-off value of >2.23, with a sensitivity of 42.31% and a specificity of 82.10%. It is summarized in Table 3 and Figure 1.

DISCUSSION
Prediction of PE in the first trimester, where maximum trophoblastic invasion occurs before the onset of the disease, is definitely an important goal. Therefore, many biochemical markers that can provide an estimate of PE are still being investigated. An ideal test should be simple, rapid, cost effective and easy to use. Positive likelihood ratio should be >15 and negative likelihood ratio should be <0.1. Its sensitivity and specificity should also be high. Today, there are no tests that are sufficient for PE prediction alone or in combination. While screening test which uses maternal obstetric history is quite   with the combined evaluation of maternal characteristics, UtA Doppler and angiogenic-antiangiogenic markers (16). The addition of maternal history and biochemical serum markers to UtA Doppler examination was strongly associated with placental and endothelial dysfunction (4,5). Serum PIGF, sEng, sFlt-1 and placental protein 13 (PP-13) make it possible to make screening earlier, and most importantly, when used with first trimester Doppler sonography, they provide a higher predictive value and more advanced diagnostic performance (5 (10,20). In a study evaluating sEng level at 11-13 and 30-33 weeks of gestation, the median MoM value at 30-33 weeks of gestation was found to be higher in preeclamptic group compared to control group, and sEng level at 11-13 weeks of gestation was found to be similar between the two groups. When maternal characteristics were combined with third trimester sEng levels, late-onset PE prediction was reported as 50% with a FPR of 10% (21). PIGF is a proangiogenic protein and PE has been associated with the production of smaller amounts of this protein. Decrease in concentration may occur during clinical symptoms and preclinical period of the disease, and it is present since first trimester. In the first trimester, preeclamptic pregnant women were found to have low PIGF concentration and it was inversely proportional to the severity of the disease (22). No difference was found between normotensive and preeclamptic patients in terms of PIGF levels tested in urine at 8-21 weeks of pregnancy. Regarding PE prediction, preterm PIGF level in the 21-32 weeks of pregnancy was higher compared to term PIGF level (23   In our study, no statistically significant difference was found between the preeclamptic group and control group in terms of these markers. We consider that this result is due to the fact that the distribution of cases was disproportionate and the number of preeclamptic cases was less than the control group. However, in subgroup analysis, it was found that PIGF level in the group 3 was significantly decreased and sEng levels were increased compared to group 2. UtA PI value was higher in preeclamptic pregnant women compared to the control group. Similar results were obtained in our study. PI value in preeclamptic group was significantly higher compared to control group (p=0.023). When PI cut-off value was taken as >2.23 in PE prediction, the sensitivity and specificity were 42.31% and 82.10%, respectively. UtA Doppler examination is an effective diagnostic tool in PE prediction.

CONCLUSION
Since UtA Doppler screening is simple and noninvasive and brings very little extra time to the duration of screening, it may be included in the current sonographic examination. The sensitivity of UtA Doppler examination may be increased by adding one or more serum markers. Combinations provide an increase in the ability of prediction and determination compared to the tests used alone.